Cargando…
Diltiazem as a cyclosporine A-sparing agent in heart transplantation: Benefits beyond dose reduction
Diltiazem (DZ) is widely prescribed in transplant recipients because of its drug-drug interactions with calcineurin inhibitors (CNI). However, these interactions have been primarily investigated in renal transplantation, and data regarding the long-term efficacy and safety of DZ in orthotopic heart...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575791/ https://www.ncbi.nlm.nih.gov/pubmed/36254022 http://dx.doi.org/10.1097/MD.0000000000031166 |